Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Jiangzhong Pharmaceutical Co Ltd    600750   CNE000000M80

End-of-day quote. End-of-day quote  - 05/24
33.18 CNY   +0.55%
 SummaryQuotesChartsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
05/18/2017 05/19/2017 05/22/2017 05/23/2017 05/24/2017 Date
34.81(c) 34.72(c) 33.9(c) 33(c) 33.18 Last
9 652 8 086 25 796 16 282 18 283 Volume
-0.14% -0.26% -2.36% -2.65% +0.55% Change
More quotes
Financials ( CNY)
Sales 2017 1 713 M
EBIT 2017 511 M
Net income 2017 463 M
Finance 2017 1 030 M
Yield 2017 1,32%
Sales 2018 1 942 M
EBIT 2018 632 M
Net income 2018 547 M
Finance 2018 1 322 M
Yield 2018 1,63%
P/E ratio 2017 21,40
P/E ratio 2018 18,12
EV / Sales2017 5,18x
EV / Sales2018 4,42x
Capitalization 9 900 M
More Financials
Company
Jiangzhong Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products.Its products include water-soluble, botanical medicine, penicillin injection, antibiotics and others.The company was founded in 1969 and is headquartered in Nanchang, China. 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Jiangzhong Pharmaceutical
Trading Rating : - Investor Rating :
More Ratings
Latest news on JIANGZHONG PHARMACEUTICAL

- No features available -

More news
Sector news : Pharmaceuticals - NEC
07:35p JOHNSON & JOHNSON : J&J settles drug manufacturing probe by U.S. states for $33 ..
06:10p FTSE edges up helped by M&S, but miners weigh
05/23DJMERCK : FDA OKs Merck's Keytruda to Treat Cancers With Genetic Defects -- Update
05/23DJMERCK : FDA Approves Merck's Keytruda to Treat Cancers With Genetic Defects
05/23DJALEXION PHARMACEUTICALS : Shakeup Continues as Four Executives Exit -- 2nd Updat..
More sector news : Pharmaceuticals - NEC
Latest Tweets
2016#Shanghai #stocks: #Merger #Acquisition: Jiangzhong Pharmaceutical : paltry g.. 
2015#Shanghai #stocks: #Merger #Acquisition: Jiangzhong Pharmaceutical : lowish g.. 
2015#Shanghai #stocks: Jiangzhong Pharmaceutical : #Markets Analysts say: fuzzy A.. 
More tweets
Qtime:2
Advertisement
Chart JIANGZHONG PHARMACEUTICAL
Duration : Period :
Jiangzhong Pharmaceutical  Technical Analysis Chart | 600750 | CNE000000M80 | 4-Traders
Full-screen chart
Technical analysis trends JIANGZHONG PHARMA...
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 42,6  CNY
Spread / Average Target 29%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Hong Guang Zhong Chairman & General Manager
Qi Yu Chairman-Supervisory Board
Juan Luo Chief Financial Officer
Min Zhi Yi Director
Lixin Liu Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
JIANGZHONG PHARMACEUTI..9.99%1 476
JOHNSON & JOHNSON10.46%342 817
ROCHE HOLDING LTD.14.79%237 610
NOVARTIS AG6.28%213 719
PFIZER INC.-1.05%191 279
MERCK & CO., INC.9.65%175 160
More Results